Biologicals

Typhoid fever

Typhoid polysaccharide vaccine

Title: Requirements for Vi Polysaccharide Typhoid Vaccine; Adopted 1992, TRS No 840, Annex 1

Typhoid vaccine, live attenuated

Title: Requirements for Typhoid Vaccine (Live, attenuated, Ty 21a, Oral); Adopted at ECBS 1983 Reference:TRS No 700, Annex 3

Typhoid vaccine

Title: Requirements for Typhoid Vaccine; Adopted 1966, TRS No 361, Annex 4

UPCOMING EVENTS

WHO Drafting Group Meeting on the Revision of TRS 962, Annex 1

(Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines) 29-30 April 2014, WHO/HQ, Geneva

Implementation Workshop on Evaluation of Biotherapeutic Products and Evaluation of Similar Biotherapeutic products with emphasis on Monoclonal Antibody Products

13-16 May 2014, Seoul, The Republic of Korea

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971